Argentina inaugurated the first Biosafety Level 4 laboratory in Latin America
President Javier Milei
porEditorial Team
Argentina
Milei's government announced that, throughout the continent, only the United States has a facility of this kind
In a historic event for science and public health in Argentina, the Government of Javier Milei announced today the launch of the first Biosafety Level 4 (BSL-4) laboratory in Latin America, located at the Biological Containment Center Operational Unit of the National Institute of Infectious Diseases ANLIS “Dr. Carlos G. Malbrán”.
The announcement, made by the Minister of Health, Mario Lugones, through his X account, marks a turning point in Argentina's healthcare capacity to face biological threats.
“WE ARE STRENGTHENING BIOSAFETY AND BIOCUSTODY TO GUARANTEE HEALTH SECURITY,” stated Lugones, emphasizing that the new facility will expand the country's ability to anticipate and contain health emergencies such as pandemics or bioterrorism attacks.
According to the minister, with this inauguration Argentina is placed at the scientific forefront of the continent, in a position that it only shares with the United States.
El recorrido inaugural del laboratorio
The BSL-4 laboratory represents the highest international category in biological safety, capable of handling high-risk infectious agents that can cause severe diseases without widely available treatments or vaccines. Among the pathogens that can be studied are viruses such as Ebola, Marburg, hantavirus, and various hemorrhagic fevers.
The facility will not only play a key role in basic research, but also in the development of rapid diagnostics, antivirals, and vaccines. It will also be essential for monitoring emerging variants and studying animal reservoirs, with the aim of anticipating and preventing possible inter-species jumps that could trigger epidemic outbreaks.
The inaugural tour of the laboratory was attended by the Chief of the Cabinet of Ministers, Guillermo Francos; the Secretary of Administrative Management, Saúl Flores; and the Director of ANLIS Malbrán, Claudia Perandones, among other national authorities.
El laboratorio
Lugones highlighted that the creation of this laboratory is the result of “efficient management and strategic planning” and stressed that it will strengthen the Argentine healthcare system in the face of future challenges.
The inauguration of the BSL-4 in Argentina not only significantly strengthens the national scientific capacity, but also positions the country as a regional benchmark in biosafety.
With this inauguration, Milei's government places science and health as strategic priorities for the country's development. The new ANLIS-Malbrán laboratory opens a new era in Argentina's ability to protect its population against highly complex biological threats.
